Chaim Gilon

10.4k total citations · 2 hit papers
228 papers, 8.7k citations indexed

About

Chaim Gilon is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Chaim Gilon has authored 228 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 155 papers in Molecular Biology, 58 papers in Organic Chemistry and 55 papers in Cellular and Molecular Neuroscience. Recurrent topics in Chaim Gilon's work include Chemical Synthesis and Analysis (101 papers), Neuropeptides and Animal Physiology (31 papers) and Click Chemistry and Applications (25 papers). Chaim Gilon is often cited by papers focused on Chemical Synthesis and Analysis (101 papers), Neuropeptides and Animal Physiology (31 papers) and Click Chemistry and Applications (25 papers). Chaim Gilon collaborates with scholars based in Israel, United States and Germany. Chaim Gilon's co-authors include Alexander Levitzki, Aviv Gazit, Amnon Hoffman, Horst Kessler, Zvi Selinger, Jayanta Chatterjee, Michael Chorev, M. Chorev, R. Laufer and Samuel Zalipsky and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Chaim Gilon

220 papers receiving 8.4k citations

Hit Papers

Tyrphostins I: synthesis and biological activity of prote... 1988 2026 2000 2013 1989 1988 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chaim Gilon Israel 45 5.7k 1.7k 1.5k 1.3k 602 228 8.7k
Michael Chorev United States 45 4.6k 0.8× 1.3k 0.8× 977 0.6× 1.1k 0.8× 499 0.8× 169 6.5k
Torsten Hoffmann Germany 34 3.5k 0.6× 1.1k 0.6× 933 0.6× 1.2k 0.9× 453 0.8× 105 6.1k
Akira Otaka Japan 50 4.6k 0.8× 2.6k 1.5× 693 0.4× 1.5k 1.1× 581 1.0× 225 7.9k
Francesc Avilés Spain 52 7.1k 1.2× 837 0.5× 739 0.5× 2.4k 1.8× 415 0.7× 266 9.9k
Carlo Pedone Italy 56 8.8k 1.5× 3.8k 2.2× 509 0.3× 1.0k 0.8× 503 0.8× 401 11.9k
Saburo Aimoto Japan 46 5.5k 1.0× 1.6k 0.9× 571 0.4× 646 0.5× 393 0.7× 195 7.6k
E. T. Kaiser United States 45 6.9k 1.2× 2.7k 1.6× 851 0.6× 960 0.7× 736 1.2× 242 9.5k
Shumpei Sakakibara Japan 48 5.0k 0.9× 969 0.6× 1.7k 1.1× 1.2k 0.9× 271 0.5× 210 7.9k
Loren D. Walensky United States 49 9.4k 1.6× 1.5k 0.8× 655 0.4× 1.9k 1.4× 607 1.0× 122 11.3k
Charles M. Deber Canada 55 7.5k 1.3× 1.0k 0.6× 900 0.6× 556 0.4× 376 0.6× 218 9.7k

Countries citing papers authored by Chaim Gilon

Since Specialization
Citations

This map shows the geographic impact of Chaim Gilon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaim Gilon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaim Gilon more than expected).

Fields of papers citing papers by Chaim Gilon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chaim Gilon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaim Gilon. The network helps show where Chaim Gilon may publish in the future.

Co-authorship network of co-authors of Chaim Gilon

This figure shows the co-authorship network connecting the top 25 collaborators of Chaim Gilon. A scholar is included among the top collaborators of Chaim Gilon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chaim Gilon. Chaim Gilon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoffman, Amnon, et al.. (2025). Anti-Inflammatory Effects of Clarstatin, a Shared-Epitope–Antagonistic Cyclic Peptide, on Experimental Autoimmune Uveitis in Mice. Investigative Ophthalmology & Visual Science. 66(1). 13–13.
2.
Gitlin‐Domagalska, Agata, Anna Olejnik, Jarosław Ruczyński, et al.. (2025). Application of Lipophilic Prodrug Charge Masking Strategy to Obtain Novel, Potential Oxytocin Prodrugs. International Journal of Molecular Sciences. 26(10). 4772–4772. 1 indexed citations
4.
Gitlin‐Domagalska, Agata, Sylwia Freza, Dawid Dębowski, et al.. (2023). Synthesis of Novel Arginine Building Blocks with Increased Lipophilicity Compatible with Solid-Phase Peptide Synthesis. Molecules. 28(23). 7780–7780. 1 indexed citations
5.
Hoffman, Amnon, et al.. (2022). PH-Binding Motif in PAR4 Oncogene: From Molecular Mechanism to Drug Design. Molecular Cancer Therapeutics. 21(9). 1415–1429. 3 indexed citations
6.
Marx, Gerard, et al.. (2021). Neural Experience of Conscious Time. 2 indexed citations
7.
Marx, Gerard, et al.. (2021). Considerations of Consciousness and Emotive Memory. 1 indexed citations
8.
Tal‐Gan, Yftah, et al.. (2011). Chemical Trapping of Vancomycin: A Potential Strategy for Preventing Selection of Vancomycin-Resistant Enterococci. Microbial Drug Resistance. 18(2). 109–115. 5 indexed citations
9.
Tal‐Gan, Yftah, Mattan Hurevich, Shoshana Klein, et al.. (2011). Backbone Cyclic Peptide Inhibitors of Protein Kinase B (PKB/Akt). Journal of Medicinal Chemistry. 54(14). 5154–5164. 24 indexed citations
10.
Hurevich, Mattan, et al.. (2010). Novel method for the synthesis of urea backbone cyclic peptides using new Alloc‐protected glycine building units. Journal of Peptide Science. 16(4). 178–185. 32 indexed citations
11.
Stanhill, Ariel, et al.. (1997). Translocation of NLS–BSA conjugates into nuclei of permeabilized mammalian cells can be supported by protoplast extract. FEBS Letters. 412(3). 535–539. 21 indexed citations
12.
Gazit, Aviv, et al.. (1993). Tyrphostins. 3. Structure-activity relationship studies of .alpha.-substituted benzylidenemalononitrile 5-S-aryltyrphostins. Journal of Medicinal Chemistry. 36(23). 3556–3564. 35 indexed citations
13.
Osherov, Nir, Aviv Gazit, Chaim Gilon, & Alexander Levitzki. (1993). Selective inhibition of the epidermal growth factor and HER2/neu receptors by tyrphostins. Journal of Biological Chemistry. 268(15). 11134–11142. 164 indexed citations
14.
Chorev, Michael, et al.. (1991). Toward nonpeptidal substance P mimetic analogues: Design, synthesis, and biological activity. Biopolymers. 31(6). 725–733. 8 indexed citations
15.
Levitzki, Alexander, Aviv Gazit, Nir Osherov, Israel Posner, & Chaim Gilon. (1991). [29] Inhibition of protein-tyrosine kinases by tyrphostins. Methods in enzymology on CD-ROM/Methods in enzymology. 201. 347–361. 69 indexed citations
16.
Gazit, Aviv, Nir Osherov, Israel Posner, et al.. (1991). Tyrphostins. II. Heterocyclic and .alpha.-substituted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinases. Journal of Medicinal Chemistry. 34(6). 1896–1907. 238 indexed citations
17.
Kolodny, Nancy H., et al.. (1989). 1H‐nmr studies of receptor‐selective substance P analogues reveal distinct predominant conformations in DMSO‐d6. Biopolymers. 28(1). 51–64. 32 indexed citations
18.
Frey, Joseph M., Ralph Laufer, Chaim Gilon, et al.. (1987). Behavioural effects of receptor-specific substance P agonists. Pain. 31(2). 263–276. 112 indexed citations
20.
Deutsch, Joseph, Chaim Gilon, & Michael Chorev. (1981). FIELD DESORPTION MASS SPECTROMETRY. International journal of peptide & protein research. 18(2). 203–207. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026